{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T20:21:28Z","timestamp":1773519688114,"version":"3.50.1"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine Reports"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.pmedr.2026.103438","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T16:26:53Z","timestamp":1772641613000},"page":"103438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Initial outcomes of a municipality-led prostate cancer screening program: Analysis of the osaka city system in a community clinic setting"],"prefix":"10.1016","volume":"64","author":[{"given":"Masamichi","family":"Yoshika","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.pmedr.2026.103438_bb0005","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1056\/NEJM200105033441806","article-title":"Clinical practice: prostate-specific-antigen testing for early diagnosis of prostate cancer","volume":"344","author":"Barry","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"18","key":"10.1016\/j.pmedr.2026.103438_bb0010","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1001\/jama.2018.3712","article-title":"Prostate-specific antigen\u2013based screening for prostate cancer: evidence report and systematic review for the USPSTF","volume":"319","author":"Fenton","year":"2018","journal-title":"JAMA"},{"issue":"9959","key":"10.1016\/j.pmedr.2026.103438_bb0015","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/S0140-6736(14)60525-0","article-title":"Screening and prostate cancer mortality: results of the European randomised study of screening for prostate cancer (ERSPC) at 13 years of follow-up","volume":"384","author":"Schr\u00f6der","year":"2014","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.pmedr.2026.103438_bb0020","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa0810084","article-title":"Screening and prostate-cancer mortality in a randomized European study (ERSPC)","volume":"360","author":"Schr\u00f6der","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.pmedr.2026.103438_bb0025","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.eururo.2019.02.009","article-title":"A 16-year follow-up of the European randomized study of screening for prostate cancer","volume":"76","author":"Hugosson","year":"2019","journal-title":"Eur. Urol."},{"key":"10.1016\/j.pmedr.2026.103438_bb0030","doi-asserted-by":"crossref","DOI":"10.3892\/mco.2022.2599","article-title":"Population-based prostate-specific antigen screening for prostate cancer may have an indirect effect on early detection through opportunistic testing in Kusatsu City, Shiga, Japan","author":"Kageyama","year":"2022","journal-title":"Mol. Clin. Oncol."},{"key":"10.1016\/j.pmedr.2026.103438_bb0035","series-title":"Osaka City Official Website","article-title":"Prostate cancer screening program (age-specific PSA cut-off and subsidy system) (in Japanese)","author":"Osaka City Government","year":"2023"},{"issue":"17","key":"10.1016\/j.pmedr.2026.103438_bb0040","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1056\/NEJMoa2503223","article-title":"European study of prostate cancer screening\u201423-year follow-up","volume":"393","author":"Roobol","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.pmedr.2026.103438_bb0045","first-page":"671","article-title":"Screening for prostate cancer in a city in Japan: age-specific PSA cutoff thresholds","volume":"35","author":"Terao","year":"2024","journal-title":"Cancer Causes Control"},{"issue":"18","key":"10.1016\/j.pmedr.2026.103438_bb0050","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2018.3710","article-title":"Screening for prostate cancer: US preventive services task force recommendation statement","volume":"319","author":"US Preventive Services Task Force","year":"2018","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.pmedr.2026.103438_bb0055","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.eururo.2024.04.036","article-title":"Systematic review on the cost-effectiveness of prostate cancer screening in Europe","volume":"86","author":"Vynckier","year":"2024","journal-title":"Eur. Urol."}],"container-title":["Preventive Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211335526000665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211335526000665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T16:41:23Z","timestamp":1773506483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211335526000665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":11,"alternative-id":["S2211335526000665"],"URL":"https:\/\/doi.org\/10.1016\/j.pmedr.2026.103438","relation":{},"ISSN":["2211-3355"],"issn-type":[{"value":"2211-3355","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Initial outcomes of a municipality-led prostate cancer screening program: Analysis of the osaka city system in a community clinic setting","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pmedr.2026.103438","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103438"}}